The UK health and fitness market has hit a new high, generating £5.7bn in annual revenue and reaching 11.5 million members across 5,607 clubs. A new industry report from ukactive, with analysis from Deloitte, highlights strong sector growth, rising gym usage, and major investment potential—even amid economic headwinds.

New research reveals UK-based fitness chain The Gym Group has generated $2.25 billion USD in social value since 2016—improving health, education outcomes, and reducing crime. It’s the first private operator to measure its impact using Sport England’s Social Value Calculator.

The NHS is urging clinicians to integrate physical activity into routine care, citing its role in preventing and managing chronic conditions—and the billions it could save the healthcare system.

Life Time has launched its LTH supplement line on Amazon, making more than 50 research-backed products accessible to a wider audience. The move comes as 71% of U.S. adults report confusion around supplement choices.

Garmin’s fēnix smartwatches are supporting spaceflight research on the Fram2 mission, collecting biometric data in orbit. Here’s what it means for the future of wearables in fitness and health monitoring.

Noom has partnered with LillyDirect® pharmacy provider Gifthealth to streamline access to Zepbound® vials for weight management, enhancing its GLP-1 Companion program for eligible users.

GymNation is turning heads with its latest concept — an in-gym hotel promising recovery without the commute. Dumbbell-shaped towels, protein-on-demand, and "Gymflix" are just the beginning. Is this the future of fitness, or something a little more tongue-in-cheek?

Novo Nordisk says unauthorized compounded versions of Wegovy are cutting into U.S. sales and warns it may pursue legal action to protect its intellectual property. The company has also expanded access to its official savings program.

Explore key insights from the 2024 Shape of America Report, revealing how weight impacts health, finances, and daily life. Learn why 75% of Americans think about their weight daily and how trends are shaping wellness in 2025.

Biden Administration proposes expanding Medicare and Medicaid to cover GLP-1 medications, addressing obesity and opening new opportunities for the fitness industry. Learn how this could reshape access to care and gym engagement.

A House of Lords report reveals that obesity is now the second leading health risk in England after tobacco. The Committee calls for urgent government action to overhaul the food system and reduce obesity rates.

New AI-powered research suggests that GLP-1 drugs, commonly used for diabetes and obesity, could prevent up to 34,000 heart attacks and strokes annually by offering cardiovascular benefits to millions of Americans.

Eli Lilly reduces the price of its obesity medication, Zepbound®, offering discounted single-dose vials to expand access for self-pay patients with an on-label prescription. Learn more about this cost-cutting initiative.

Eli Lilly's tirzepatide shows a 94% reduction in diabetes risk and significant weight loss in adults with pre-diabetes and obesity, according to a three-year study.

Explore the shift in GLP-1 drug use as a growing number of non-diabetics turn to these medications for weight loss. Understand the new trends and their impact on diabetes care.

A recent ukactive survey reveals that 85% of UK adults prefer the Government to invest in long-term obesity prevention rather than weight-loss drugs. Discover public opinions on health priorities, mental health support, and the role of gyms in healthcare.

Discover how Ozempic and other GLP-1 agonists may reduce the risk of obesity-associated cancers in a recent study of obese patients. Learn more about the potential cancer-preventive effects of these diabetes medications.

Combining GLP-1 drugs like liraglutide with exercise helps maintain bone health during weight loss, according to a recent study. Learn how this approach can balance weight loss and bone density preservation.

Top wellness leaders from CrossFit, Sweetgreen, Thrive Market, and more form End Chronic Disease, an advocacy group promoting exercise, healthy eating, and lifestyle changes to combat chronic illness and shift healthcare priorities.

Form Health, a leading provider of science-based obesity care in the U.S., secures $38 million in Series B funding to expand enterprise partnerships, hire ABOM-certified physicians, and enhance telehealth technology.